New approaches to Polypharmacy: Oligopharmacy and Deprescribing
|
|
- Dayna Nelson
- 5 years ago
- Views:
Transcription
1 East & outh East England pecialist harmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety New approaches to olypharmacy: Oligopharmacy and Deprescribing Nina Barnett, Consultant harmacist, Care of Older eople North West London Hospitals NH Trust NH East & outh East pecialist harmacy ervices Lelly Oboh, Consultant harmacist, Care of Older eople GTT NH Trust and NH East & outh East pecialist harmacy ervices East & outh East England pecialist harmacy ervices MU Team: Winner: R harmaceutical Care award 2013; Finalist: HJ atient safety in primary care award 2013; Winner: UKCA/Guild Conference Best oster award 2013; Winner: UKCA ain award 2012; Winner: UKCA Respiratory award 2012
2 Medicines Use and afety olypharmacy itself should be conceptually perceived as a disease with potentially more serious complications than those of the diseases these different drugs have been prescribed for Doron Garfinkel 2010
3 Medicines Use and afety Who is at risk?- Frail older people What is frailty? Aged over 75, often over 85, with multiple diseases, which may include dementia. (BG definition) Reduced functional reserve more vulnerable to developing complications while in hospital Less resilient to external stressors and take more time to recover Often present to hospital with geriatric syndromes such as falls, immobility and confusion
4 Medicines Use and afety Oligopharmacy Deliberate avoidance of polypharmacy i.e. less than 5 prescription drugs daily (O Mahoney) Deprescribing The complex process required for the safe and effective cessation (withdrawal) of inappropriate medications Takes into account the patient s physical functioning, co-morbidities, preferences and lifestyle.
5 Medicines Use and afety Deprescribing:getting the right balance Life expectancy, comorbidity burden, care goals patient preferences, benefits of medicines ADRs, risks and harms of medicines
6 Medicines Use and afety How to identify frailty? Morley JE et al. J Am Med Dir Assoc ; 2013 Jan 1;14(6):392 7
7 What the literature show 1-3 Medicines Use and afety No long term outcome data...but, reduces drug usage/costs & unlikely to cause harm Must involve patients, carers & multidisciplinary working There s enough evidence to stop certain drugs Many challenges and barriers Clinical and communication skills are important Must be done sequentially, slowly over a period of time Time consuming & dynamic process requiring extensive communication, frequent monitoring and review, tructured approach needed (7 steps)
8 What the literature show 1-3 Medicines Use and afety 7 key steps 1. Assess patient 2. Define overall patient goals 3. Identify inappropriate drugs from an accurate list of medication 4. Assess each drug for specific risks vs benefits in context 5. Decide to stop or reduce dose 6. Communicate with G/prescriber 7. Monitor regularly and adjust accordingly
9 Medicines Use and afety Garfinkel et al 2010 Feasibility study of a systematic approach for discontinuation of multiple medication in older adults 70 community dwelling older adults (Feb 05-Jun 08) Follow up every 3-6 months Algorithm based on evidence for drug indication Algorithm identified 311drugs (in 64 pts) to stop 256 drugs considered after family discussion 81% discontinued 2% restarted 88% reported global improvements in health. 100% success for benzodiazepines
10 The Good alliative Geriatric ractice algorithm Medicines Use and afety
11 Medicines Use and afety O Mahoney et al (of TO/TART fame ) Review of principles for best practice in oligopharmacy Focus is End-of-life or pre-terminal phase Differentiates btwn starting new drugs vs stopping existing drugs uggests using TO tool to identify drugs for stopping Considers suitability/need for drug classes rather than indication for prescribing (cf Garfinkel) Drugs for primary and life extension Drugs for secondary prevention except benefits Aim for <5 medicines, minimise tablet count and doses per day Optimise formulation and administration methods (liaise with community pharmacist) & refer for MUR where appropriate
12 Medicines Use and afety Hilmer 2012 Evidence based discussion for appropriate prescribing and deprescribing Differentiates between robust vs frail older people Considers appropriateness based on current poor evidence for commonly prescribed medicines in older people Drug assessment based on adherence, ADRs, indications and interactions Considers ethical principles Multidisciplinary support required for G to deprescribe safely
13 Key steps in optimising an older patient's medical therapy
14 ummarising the literature Medicines Use and afety Key steps Garfinkel O Mahoney Hilmer 1. Assess patient 2. Define overall patient goals 3. Identify inappropriate drugs from accurate list of medication G-G Algorithm TO tool EBM/ethics 4. Assess each drug for specific risks vs. benefits in context G-G Algorithm Life extending 1 0 /2 0 prevention drugs ADR, adherence, indication, interactions 5. Decide to stop or reduce dose 6. Communicate with G 7. Monitor regularly and adjust accordingly
15 A structured approach to reducing polypharmacy: Key stages Medicines Use and afety Monitor regularly & adjust Communicate with G Decide to stop or reduce dose Assess each drug for specific risks & benefits in the context of individual patient Identify inappropriate drugs from accurate medicines list Define overall treatment goals Assess patient
16 Assess patient Medicines Use and afety With patient and carers Medical history Functional history Estimate frailty, life expectancy (NH highland tool 4 ) & trajectory decline
17 Define overall goal Medicines Use and afety In frail older patients, the main priorities are ymptom control Maintaining function Addressing end-of-life issues Maintaining dignity
18 Medicines Medicines Use and Use afety and afety Identify inappropriate drugs from an Tools accurate list of medication Evidence/consensus guidance to support its use in older people Estimates of risks/benefits 4 TO tool 5 G-G algorithm MAI tool 6 Clinical judgement and experience Does each drug have a matching indication, is indication still valid? Does the drug produce limited benefit for that indication Is it a high risk drug? Are the benefits overweighed by unfavourable ADRs in O
19 Medicines Use and afety Inability to apply existing knowledge to a new and complex situation contributes more often to the occurrence of adverse events in older than younger patients Merten Het al. cale, nature, preventability and causes of adverse events in hospitalised older patients. Age Ageing 2012;
20 Medicines Use and afety Assess each drug for specific risks & benefits in the context of patient circumstance EACH medicine is tailored to the patient s Defined overall goal Circumstances Clinical reality and social situation Morbidities Experience, preferences and ability to comply Life expectancy
21 Medicines Use and afety If shortened life expectancy, query... Drugs for primary prevention No place Drugs for secondary prevention ONLY if time to benefit exceeds life expectancy Lipid lowering drugs revention of fragility # ACEI, ARB, BB to prevent diabetic neuropathy/hf mortality Memantine for improved cognition
22 Medicines Use and afety Decide to stop or reduce dose Discontinue top one at a time Gradually Consider rebound Enlist help of peers or specialists Continue Optimise therapy Reduce dose/frequency/ prn ubstitute with a safer drug, formulation, schedule Wait and see
23 Medicines Use and afety Communication with G rioritise repare a range of options for each drug resent in a simple format Face to face with prescriber is best Follow up with written summary, highlighting Evidence base/rationale Agreed action for each drug and monitoring
24 Medicines Use and afety
25 Medicines Use and afety Barriers to change re-empt resistance, easier to maintain the status quo! Easy to start drugs but difficult to stop Little evidence/guidance on how to deprescribe safely medico legal considerations Withdrawal in older people can be unpredictable/risky Time consuming re changing, monitoring/follow up G reluctance to stop drugs tarted by specialists Where there is a +ve guideline recommendation Consent and capacity issues in older people
26 Medicines Use and afety Regular monitoring & adjust Be clear about what monitoring is needed and ensure its in place Look out for ADRs, toxicity, benefits Look out for non specific ADRs- geriatric syndromes Review as needed or at least 3-6 months Communicate with others about changes
27 Medicines Use and afety ummary: Oligopharmacy and Deprescribing is everybody s business tructured approach integrated with clinical judgement is required. Acknowledgment that some meds may be restarted it s a trial Full engagement of patient, family, carers is imperative and honesty all round harmacists can lead the process but must work with MDT hare the workload with specialists atients, relatives, carers, community pharmacists, OTs, nurses etc can monitor drug effects and feedback Focus on patients with the highest medication related risks and morbidities For individual patients, focus on the drugs with the highest risks or highest benefits
28 Medicines Use and afety References 1. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch. Intern Med 2012;170: O Mahony, O Connor. harmacotherapy at the end-of-life. Age and ageing 2011;40; Hilmer N, Gnjidic D and Le Couteur D.Thinking through the medication list. Australian Family hysician 2012 Vol 41 no 12, p NH Highland. olypharmacy: Guidance for prescribing in frail elderly Gallagher et al. creening tool of older people s potentially inappropriate prescriptions. Int J Clin harmacol Ther 2008;46: Hanlon J et al. Medication Appropriateness Index- MAI. J Clin Epidemiol 1992;45: Further reading 1. teinman M, Hanlon J. Managing medications in complex elders: There s got to be a happy medium. JAMA 2010;304(14): Gnjidic et al, Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012 May;28(2): Ian A cott et al. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evidence-Based Medicine 2012
A collaborative evaluation of the number and clinical significance of pharmacy interventions to the care of inpatients in Community Hospitals
East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety A collaborative evaluation of the number and clinical significance of
More informationMEDICINES USE AND SAFETY WEBINAR
MEDICINES USE AND SAFETY WEBINAR Welcome to the Medicines Use and Safety Team Webinar: Medicines and Frailty with Lelly Oboh The webinar itself will start at 1pm in the meantime Carina Livingstone is doing
More informationOutcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians
Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Executive summary Australia has a significant opportunity to improve the quality use
More informationEvidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia
Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia ADI 2018, Chicago FACULTY OF MEDICINE Dr Emily Reeve NHMRC Cognitive Decline
More informationPOLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group
POLYPHARMACY A practical approach to deprescribing in care homes. Care Home Pharmacy Team Herts Valleys Clinical Commissioning Group Neeta Gulhane Specialist Pharmaceutical Advisor Care Homes The Care
More informationAkinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),
Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271 Copyright: This is an Accepted Manuscript of an article published by Taylor
More informationDisclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.
The elderly at risk: reducing medications safely to meet life s changes Barbara Farrell BScPhm, PharmD, FCSHP European Society of Hospital Pharmacists Conference March 2017 Disclosure Relevant financial
More informationPolypharmacy and Deprescribing for Older People
Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University
More informationPolypharmacy & De-prescribing In Older Adults
Polypharmacy & De-prescribing In Older Adults Maryland Association of Osteopathic Physicians Annual Meeting September 15, 2018 Elizabeth Phung, DO Lead Clinical Associate Physician Beacham Center for Geriatric
More informationDeprescribing: A Practical Guide
Deprescribing: A Practical Guide The information in this booklet should be used as a pragmatic decision aid, in conjunction with other relevant patient specific data. Useful resource links http://www.derbyshiremedicinesmanagement.nhs.uk/assets/clinical_guidelines/clinical_guidelines_fr
More informationIV Referral Standards for OPAT Services
pecialist harmacy ervice Medicines Use and afety IV Referral tandards for OAT ervices andra Wolper Associate Director Medicines Use and afety Division pecialist harmacy ervices pecialist harmacy ervice
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationDeprescribing: tackling increasing polypharmacy
CONFERENCE REPORT Deprescribing: tackling increasing polypharmacy JANET KRSKA, RACHEL HOWARD AND NINA BARNETT Deprescribing is less more? was the theme of this year s annual scientific meeting organised
More informationCover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium
If using any content from this document, please acknowledge the Scottish Government Polypharmacy Model of Care Group, 2018. When referencing this document, please use the following format: Scottish Government
More information< = > less is more. De-diagnosing De-prescribing Non-testing
< = > less is more De-diagnosing De-prescribing Non-testing Who says? Overdiagnosis Polypharmacy False positives Too much medicine Risk aversion $$$ Sources Prof David Le Couteur, Clin Pharm and Aged Care
More informationHome MURs for vulnerable older people
8 This module is also online at pharmacymagazine.co.uk CPD MODULE module 258 Home MURs for vulnerable older people Contributing author: Lelly Oboh, consultant pharmacist, care of older people WORKING IN
More informationEvidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine
Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine Developing organisations: The University of Sydney NHMRC Partnership Centre: Dealing with Cognitive
More informationStreamlining Memory Service Pathways. Guidance from the London Dementia Clinical Network
Triage Initial Assessment Investigations 2nd Appointment Streamlining Memory Service Pathways Guidance from the London Dementia Clinical Network London Dementia Clinical Network July 2017 1 Contents Introduction...
More informationDeprescribing: reducing inappropriate polypharmacy
MEDICINES OPTIMISATION Deprescribing: reducing inappropriate polypharmacy ANGELA DOWDEN Inappropriate prescribing and polypharmacy, particularly in elderly patients, is associated with increased risk of
More informationReview of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH
POLYPHARMACY IN ASSISTED LIVING A Evidence Based Approach to Management of Medication Regimen Complexity By Burton Korer, MSN, RN-BC, CPHQ EVIDENCE BASED APPROACH Evidence-based practice (EBP) is the conscientious
More informationPolypharmacy in the Elderly
Polypharmacy in the Elderly Or How Scotland invented the Modern World Sir William Ferguson Anderson 1914-2001 Became the first Professor of Geriatrics in the world when he was appointed to the David Cargill
More informationIan Scott. Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital
National Workshop in Deprescribing Setting the scene Ian Scott Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital Associate Professor of Medicine University of Queensland
More informationNICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56
Multimorbidity: clinical assessment and management NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationRationalizing Medications. Tan Jianming Senior Pharmacist KTPH
Rationalizing Medications Tan Jianming Senior Pharmacist KTPH + Older patients are more likely to: 2 Have multiple co-morbid diseases Have age-related physiological changes that result in a reduced tolerance
More informationMedicines Optimisation the opportunities and challenges. Christina Short Medicines Optimisation Project Manager
Medicines Optimisation the opportunities and challenges Christina Short Medicines Optimisation Project Manager The remit:- Clinical Pharmacy input into the Locality Model Proposal: To contract a senior
More informationManaging Behavioural Problems in Patients with Learning Disabilities
Managing Behavioural Problems in Patients with Learning Disabilities Some people with a learning disability display behaviour that challenges. Although such behaviour is a challenge to services, family
More informationINTEGRATED GERIATRIC AND PRIMARY CARE MANAGEMENT OF FRAIL OLDER ADULTS IN THE COMMUNITY
INTEGRATED GERIATRIC AND PRIMARY CARE MANAGEMENT OF FRAIL OLDER ADULTS IN THE COMMUNITY LM Pérez (1), P Burbano (1), M Hernandez (1), N Gual (1,2), G Liesa (1), E Martin (3), L Tobella (3), MB Enfedaque
More informationWhat is Frailty? National Background and Local Pathways
What is Frailty? National Background and Local Pathways Learning Outcomes At the end of the session you will be able to :Know where to go to look at key national resources on frailty. Define frailty. Screen
More informationFrailty Care a matter of national social injustice
Frailty Care a matter of national social injustice Authors: Dr Steve Feast, Managing Director, Eastern Academic Health Science Network, steve.feast@eahsn.org Professor David Hewson, Professor of Health
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More informationOptimising medication in frail older people
MEDICINES OPTIMISATION Optimising medication in frail older people MARYAM JIWA Medicines optimisation is key to the successful management of frail older people in order to reduce harm and minimise inappropriate
More informationSafe Prescribing in Dementia
Safe Prescribing in Dementia Dr Daniel Harwood Consultant Psychiatrist and Clinical Director, London Strategic Clinical Network Gurdeep Kaur Major Rapid Access Team Senior Pharmacist, Camden CNWL NHS Trust
More informationFrailty: what s it all about?
Frailty: what s it all about? What is frailty? 1. an inevitable consequence of aging 2. A state due to multiple long term conditions 3. A condition in which the person becomes fragile 4. A state associated
More informationCommunity Pharmacy NSAID Audit on Gastrointestinal Safety
East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Community Pharmacy NAID Audit on Gastrointestinal afety Introduction
More informationThe Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability
The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability Danielle Adams Principal Clinical Pharmacist Pharmacy and Medicines Optimisation Team HPFT July 2017 1
More informationLe politerapie complesse: l'arte del deprescribing. Andrea Corsonello IRCCS INRCA - Cosenza
Le politerapie complesse: l'arte del deprescribing Andrea Corsonello IRCCS INRCA - Cosenza Archibald Leman Cochrane (12 January 1909 18 June 1988) was a Scottish doctor noted for his book Effectiveness
More informationAgeing Well. Avoiding falls in older people. Prof Martin Vernon NCD Older People. Find Recognise Assess Intervene Long-term.
Ageing Well Avoiding falls in older people Prof Martin Vernon NCD Older People 21 October 2016 1 Its not how old we are, but how we are old 2 Key points 1. Demography 2. Frailty & falls 3. Routine frailty
More informationProviding NHS Healthcare in Care Homes: a geriatrician s experience
Margaret Butterworth Care Homes Forum KCL July 10 th 2013 Providing NHS Healthcare in Care Homes: a geriatrician s experience Professor Finbarr C Martin, Geriatrician Guys & St Thomas Hospital and King
More informationDeprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationOlder People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG
Older People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG Wednesday 2 nd November 2016 A workshop to identify tractable research
More informationSupplemental materials for:
Supplemental materials for: Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians views on deprescribing in everyday practice. Ann Fam Med. 2017;15(4):341-346. General Practice
More informationAgeing Well. The challenge of our ageing population. Martin Vernon NCD Older People. Find Recognise Assess Intervene Long-term.
Ageing Well The challenge of our ageing population Martin Vernon NCD Older People 7 th June 2017 1 Projected UK age structure Foresight, 2016 2 Ageing impacts 15 million live with a long term condition
More informationThere s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationSubstance Misuse in Older People
Substance Misuse in Older People Dr Tony Rao Consultant Old Age Psychiatrist, SLAM NHS Foundation Trust Visiting Researcher, Institute of Psychiatry, Neurology and Neuroscience Chair of Substance Misuse
More informationIntegrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations. Dr Christina MAW Hospital Authority, Hong Kong
Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations Dr Christina MAW Hospital Authority, Hong Kong Hospital Authority (HA) of Hong Kong A statutory body responsible
More informationDeprescribing Trials: Methods to Reduce Polypharmacy and the Impact on Prescribing and Clinical Outcomes
Deprescribing Trials: Methods to Reduce Polypharmacy and the Impact on Prescribing and Clinical Outcomes Danijela Gnjidic, PhD, MPH a,b,c,, David G. Le Couteur, MBBS, PhD b,c,d, Lisa Kouladjian, BMedSc
More informationMedicines optimisation for older people with disabilities
Medicines optimisation for older people with disabilities Riddhika Joshi Care of older people and stroke pharmacist Objectives Medicines Optimisation Examples Identifying patients PREVENT Targeting patients
More informationSame day acute frailty services
Ambulatory emergency care guide Same day acute frailty services Published by NHS Improvement, NHS England, the Ambulatory Emergency Care Network and the Acute Frailty Network June 2018 Contents Introduction...
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationAbout ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org
Less is More: An Introduction to Deprescribing Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About ISMP Canada The Institute for Safe Medication Practices Canada
More informationAppropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board
Appropriate prescribing and deprescribing for older people getting it right Alan Davis Northland District Health Board Unused returns Potentially inappropriate medication use in the elderly 15% of older
More informationPolypharmacy and Deprescribing. A special report on views from the PrescQIPP landscape review
Polypharmacy and Deprescribing A special report on views from the PrescQIPP landscape review Introduction and background In recent years, we have seen the emergence of an international discussion around
More informationCommunity Programs & Minimising Frailty in Older People
VITALITY CLUB Community Programs & Minimising Frailty in Older People Presented by Theeban Rubasingham & Ahilan St George Vitality Club Directors & Co-Founders Outline of talk: 1. The Founders 2. The Vitality
More informationTest and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire
Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Introduction This document introduces South Gloucestershire Clinical Commissioning
More informationGOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4
GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services
More informationDementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context
Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context Lelly Oboh Consultant Pharmacist, Care of older people and
More informationPharmaceutical Society of Singapore Pharmacy Week Polypharmacy in Singapore: The Role of Deprescribing
Pharmaceutical Society of Singapore Pharmacy Week 2015 Polypharmacy in Singapore: The Role of Deprescribing Introduction In Singapore, life expectancy has continually increased due to greater accessibility
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationFeasibility of Implementing Advance Directive in Hong Kong Chinese Elderly People
Asia Pacific Regional Conference in End-of-Life and Palliative Care in Long Term Care Settings Feasibility of Implementing Advance Directive in Hong Kong Chinese Elderly People Dr. Patrick CHIU MBBS (HK),
More informationAssociation between Potentially Inappropriate Prescription (PIP) and Health Outcome Among Geriatric Home Residents
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (6), Page 4660-4665 Association between Potentially Inappropriate Prescription (PIP) and Health Outcome Among Geriatric Home Residents Moatassem
More informationReshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality
Reshaping Care Pathways for Older People Anne Hendry National Clinical Lead for Quality Reshaping Care for Older People 10 Year Programme to 2021 300 million Change Fund to 2015 32 Partnerships between
More informationAssessing the utility of simple measures of frailty in older hospital-based cardiology patients. by Yong Yong Tew (medical student)
Assessing the utility of simple measures of frailty in older hospital-based cardiology patients by Yong Yong Tew (medical student) Declaration No conflict of interest. Ethical considerations Reviewed and
More informationAnnual General Meeting North Hampshire CCG successes
Annual General Meeting North Hampshire CCG successes The CCG s Vision: 2015/16 To place each patient at the centre of their own health To make a positive impact on the health and wellbeing of our population
More information20th June Integrated Care in Sunderland: Guide to Risk Stratification
20th June 2017 Integrated Care in Sunderland: Guide to Risk Stratification Table of Contents Integrated Care in Sunderland:... 1 Guide to Risk Stratification... 1 Table of Contents... 2 Background... 3
More informationAppendix 1. Cognitive Impairment and Dementia Service Elm Lodge 4a Marley Close Greenford Middlesex UB6 9UG
Appendix 1 Mr Dwight McKenzie Scrutiny Review Officer Legal and Democratic Services Ealing Council Perceval House 14 16 Uxbridge Road Ealing London W5 2HL Cognitive Impairment and Dementia Service Elm
More information23/11/2018. Tools to stratify patients for clinical pharmacy interventions
Tools to stratify patients for clinical pharmacy interventions Professor Mike Scott Director of the Regional Medicines Optimisation Innovation Centre (MOIC) 47 th ESCP Symposium, Belfast 24 th October
More informationCarrying out a structured medication review
n MEDICINES OPTIMISATION Carrying out a structured medication review SHARON COANE and ROSALYNE PAYNE As part of our series on the NICE guideline on Medicines Optimisation, Sharon Coane and Rosalyne Payne
More informationItem No: 10. Meeting Date: Wednesday 20 th September Glasgow City Integration Joint Board. Alex MacKenzie, Chief Officer, Operations
Item No: 10 Meeting Date: Wednesday 20 th September 2017 Glasgow City Integration Joint Board Report By: Contact: Alex MacKenzie, Chief Officer, Operations Anne Mitchell, Head of Older People & Primary
More informationNational Frailty Approach
Ageing Well Quality Healthcare in Later Life National Frailty Approach Martin Vernon National Clinical Director Older People 1 Crawley www.england.nhs.uk 10 th May 2018 Ambition for frailty.. Everybody
More informationTaking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian
Taking the harm out of Polypharmacy Step by step Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian Presentation: Polypharmacy Overview of the 2015 guidelines The Seven Steps Application
More informationHow to prevent delirium in nursing home. Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium
How to prevent delirium in nursing home Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium 1 CONFLICT OF INTEREST DISCLOSURE I have no potential conflict of interest to report 2 Outline 1. Introduction
More informationMurthy Gokula MD,CMD
Murthy Gokula MD,CMD MEDICATIONS & LIFE EXPECTANCY DON T ROUTINELY PRESCRIBE LIPID-LOWERING MEDICATIONS IN INDIVIDUALS WITH A LIMITED LIFE EXPECTANCY: AAHPM About Choosing Wisely First conceived by the
More informationBriefing Document on Medication use and Falls
Briefing Document on Medication use and Falls This document is intended as a briefing document and is not to be regarded as a document offering definitive legal advice in relation to the subject matter.
More informationShared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes
Shared decision making for stepdown and stopping decisions Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes 1 Disclosures I have had travel and lodging paid for
More informationBulletin Independent prescribing information for NHS Wales
Bulletin Independent prescribing information for NHS Wales July 2016 Optimising medicines use in care homes There are currently over 22 000 resident places in older adult care homes in Wales. 1 An ageing
More informationPolypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics
Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse
More informationJupiter Ward Dementia Friendly Environment report Introduction: Background. Evidence for change 1, 2, 3, 4, 6 :
Jupiter Ward Dementia Friendly Environment report Introduction: Jupiter ward is a 3 bedded Older Persons Care (OPC) ward which re-opened in November 214 following a total refurbishment. The project involved
More informationCare homes: Good practice guide to prescribing and medication reviews
B112i. October 2015 Care homes: Good practice guide to prescribing and medication reviews The effective management of medicines in care homes requires robust systems to be in place as well as good communication
More informationAppendix 1: Service self-assessment
Appendix 1: Service self-assessment Frailty Screening Are we delivering high-quality care for frail older people? We are assessing for frailty in people aged 65+ at every entry into the service using a
More informationThinking Ahead in Palliative Care
Thinking Ahead in Palliative Care Annual Conference 2011 Scottish Partnership for Palliative Care Annual Conference: Thinking Ahead in Palliative Care Thursday 6 th October 2011 Advance care planning
More informationSelecting the right patient for medication reviews
Selecting the right patient for medication reviews Prof dr Petra Denig, Clinical Pharmacy & Pharmacology, University Medical Center Groningen, the Netherlands 2 Who is in need of medication review: can
More informationNHS RightCare Frailty Pathway An optimal frailty system
NHS RightCare Frailty Pathway An optimal frailty system Martin Vernon National Clinical Director for Older People Adrian Hopper Consultant Physician & Frailty Pathway GiRFT Lead Alex Thompson Pathways
More informationStop Delirium! A complex intervention for delirium in care homes for older people
Stop Delirium! A complex intervention for delirium in care homes for older people Final report Summary September 2009 1 Contents Abstract...3 Lay Summary...4 1. Background...6 2. Objectives...6 3. Methods...7
More informationPolymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy
Polymedication in nursing home Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents
More informationRecommendations from the Devon Prisons Health Needs Assessment. HMP Exeter, HMP Channings Wood and HMP Dartmoor
from the Devon Prisons Health Needs Assessment HMP Exeter, HMP Channings Wood and HMP Dartmoor 2011-2012 In April 2006 the responsibility for prison healthcare transferred from HM Prison Service to the
More informationPSYCHOTROPIC SOLUTIONS
PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationHealthy Mind Healthy Life
Healthy Mind Healthy Life onyourmind.org.uk A plan to support children and young people s emotional wellbeing and mental health in Wiltshire Children & Young People s Trust Our Vision This is a plan that
More informationMental Health in STH Mike Richmond, Medical Director Mark Cobb, Clinical Director of Professional Services Debate & Note
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE TRUST HEALTHCARE GOVERNANCE COMMITTEE E TO BE HELD ON 27 FEBRUARY 2012 Subject: Supporting Director: Author: Status 1 Mental
More informationDelirium. Quick reference guide. Issue date: July Diagnosis, prevention and management
Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide
More informationSAFE HIP FRACTURES. Dr Karthik Kayan MD FRCP Consultant Physician and Orthogeriatrician Stockport NHS Foundation Trust
SAFE HIP FRACTURES Dr Karthik Kayan MD FRCP Consultant Physician and Orthogeriatrician Stockport NHS Foundation Trust Why hip fracture? Common in older adult (~84 years) UK current incidence : 70000 (Stockport
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationRational prescribing in the older adult. Assoc Prof Craig Whitehead
Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade
More informationIntegrated Diabetes Care in Oxfordshire -patient's perspective. Avril Surridge
Integrated Diabetes Care in Oxfordshire -patient's perspective Avril Surridge Today How does diabetes care in Oxfordshire look like from a patient s perspective? Good things What could be improved? National
More informationDavid Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care
David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care Geriatrics Clinic- Providence VAMC VA Grand Rounds
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Recognising and managing bipolar disorder in adults in primary care bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are
More informationHandgrip strength as a health screening tool. Dr Kinda Ibrahim, Research Fellow in Geriatric Medicine.
Handgrip strength as a health screening tool Dr Kinda Ibrahim, Research Fellow in Geriatric Medicine. K.Ibrahim@soton.ac.uk Background Nearly two thirds of people admitted to hospital in the UK are aged
More informationMedicines Management Team Update
Medicines Management Team Update Medicines Optimisation in 2017 Deprescribing/reducing variation Care homes Dietetics Improving Clinical outcomes e.g. reducing stroke, Antibiotics Joint Formulary Responses
More informationPolypharmacy Strategy for NHS Fife
Polypharmacy Strategy for NHS Fife 2016-19 1 Introduction The purpose of this document is to describe the factors contributing to the issue of inappropriate polypharmacy as it relates to NHS Fife and proposes
More informationObjectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module
Polypharmacy Seminar Objectives On completion of this module you should be able to: state the major guiding principles in rational prescribing recognise, and substantiate, over-prescribing or inappropriate
More information